Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Príomhchruthaitheoir: | Tabassum, Nadira |
---|---|
Rannpháirtithe: | Yasmin, Hasina |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2024
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/22868 |
Míreanna comhchosúla
-
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
de réir: Karmaker, Swastika
Foilsithe / Cruthaithe: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
de réir: Mahee, Sadique Abdal
Foilsithe / Cruthaithe: (2024) -
A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
de réir: Shehab, Habibul Mohsin
Foilsithe / Cruthaithe: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
de réir: Jahan, Nusrat
Foilsithe / Cruthaithe: (2023) -
A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
de réir: Bakar, Osama Bin Abu
Foilsithe / Cruthaithe: (2024)